Description BPC-157 (Body Protection Compound-157, CAS 137525-51-0) is a synthetic 15-amino-acid pentadecapeptide derived from a sequence identified in human gastric juice, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
We excluded patients with cirrhotic liver, history of gall bladder, biliary disorders, pancreatic diseases, interrupted use of GLP-1RAs throughout the study period, and patients used other drugs with potential effects on the motility of biliary tracts such as cholecystokinin, motilin hormone, cholinomimetic agents like prostigmine, erythromycin, cisapride, cholystyramine, intravenous aminoacids, cholinergic agents like atropine, somatostatin, and progesterone, trimebutine, loperamide and ondansetron
Use consistently: Daily intake supports steady antioxidant levels
By combining these mechanisms, GLP-1 medications make weight loss more effective and sustainable
So, we had to quantify this evidence to show that it stemmed from the FDA approval and how to contain the risk
